102 related articles for article (PubMed ID: 1811222)
1. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
Płaźnik A; Kostowski W
Pol J Pharmacol Pharm; 1991; 43(4):301-22. PubMed ID: 1811222
[No Abstract] [Full Text] [Related]
2. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in animal models of depression and antidepressant response.
Dalla C; Pitychoutis PM; Kokras N; Papadopoulou-Daifoti Z
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):226-33. PubMed ID: 20050844
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic mediation effects of St John's wort in rats subjected to swim stress.
Bano S; Dawood S
Pak J Pharm Sci; 2008 Jan; 21(1):63-9. PubMed ID: 18166522
[TBL] [Abstract][Full Text] [Related]
5. The development of our understanding of the mechanism of action of antidepressant drugs.
Vetulani J
Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
[No Abstract] [Full Text] [Related]
6. Stress-induced depression of basal motility: effects of antidepressant drugs.
Zebrowska-Lupina I; Stelmasiak M; Porowska A
Pol J Pharmacol Pharm; 1990; 42(2):97-104. PubMed ID: 2274476
[TBL] [Abstract][Full Text] [Related]
7. Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.
Sánchez C; Brennum LT; Stórustovu Sí; Kreilgård M; Mørk A
Pharmacol Biochem Behav; 2007 Mar; 86(3):468-76. PubMed ID: 17303232
[TBL] [Abstract][Full Text] [Related]
8. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
Li YC; Wang FM; Pan Y; Qiang LQ; Cheng G; Zhang WY; Kong LD
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):435-49. PubMed ID: 19302828
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression.
Kim SH; Han J; Seog DH; Chung JY; Kim N; Hong Park Y; Lee SK
Life Sci; 2005 Jan; 76(11):1297-306. PubMed ID: 15642599
[TBL] [Abstract][Full Text] [Related]
12. Effect of antidepressant on behavior and central catecholamine of depression-model rats.
Kitayama I; Murase S; Koishizawa M; Kawaguchi S; Nomura J
Yakubutsu Seishin Kodo; 1987 Dec; 7(4):433-6. PubMed ID: 3452275
[TBL] [Abstract][Full Text] [Related]
13. The influence of psychotropic drugs on the level and metabolism of noradrenaline in brain and behavior of rats.
Herman ZS
Arch Immunol Ther Exp (Warsz); 1970; 18(5):571-83. PubMed ID: 4395426
[No Abstract] [Full Text] [Related]
14. [Studies on animal model of depression: review and perspective].
Nomura S; Yamaoka K; Naitoh H
Yakubutsu Seishin Kodo; 1989 Dec; 9(4):349-58. PubMed ID: 2698019
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant agents. VI. 4,4-Diphenyl-1-methylcyclohexylamines.
Carnmalm B; Persson ML; Ross SB; Ogren SO; Stjernström NE
Acta Pharm Suec; 1975; 12(2):205-8. PubMed ID: 1163238
[No Abstract] [Full Text] [Related]
16. The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.
Grahame-Smith DG
Adv Biochem Psychopharmacol; 1984; 39():327-43. PubMed ID: 6464831
[No Abstract] [Full Text] [Related]
17. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
18. Invivo antioxidant status: a putative target of antidepressant action.
Zafir A; Ara A; Banu N
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic modulation of cortical rat noradrenergic system in the mechanism of action of antidepressant drugs.
Brunello N; Mocchetti I; Volterra A; Cuomo V; Racagni G
Psychopharmacol Bull; 1985; 21(3):379-84. PubMed ID: 4034853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
